Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria – a proposed model-derived age-based regimen for sub-Saharan Africa

Autor: Taylor, W Robert, Naw, Htee Khu, Maitland, Kathryn, Williams, Thomas N, Kapulu, Melissa, D’Alessandro, Umberto, Berkley, James A, Bejon, Philip, Okebe, Joseph, Achan, Jane, Amambua, Alfred Ngwa, Affara, Muna, Nwakanma, Davis, van Geertruyden, Jean-Pierre, Mavoko, Muhindo, Lutumba, Pascal, Matangila, Junior, Brasseur, Philipe, Piola, Patrice, Randremanana, Rindra, Lasry, Estrella, Fanello, Caterina, Onyamboko, Marie, Schramm, Birgit, Yah, Zolia, Jones, Joel, Fairhurst, Rick M, Diakite, Mahamadou, Malenga, Grace, Molyneux, Malcolm, Rwagacondo, Claude, Obonyo, Charles

Publikováno v: BMC Medicine

BACKGROUND: In 2012, the World Health Organization recommended blocking the transmission of Plasmodium falciparum with single low-dose primaquine (SLDPQ, target dose 0.25 mg base/kg body weight), without testing for glucose-6-phosphate dehydrogenase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3158::737096911be3c395ce1cfdc5f5f500d0
http://hdl.handle.net/11427/34323

Survey Techniques to Capture Sensitive Information from Health Workers: An Example of Their Application in Liberia

Autor: David C. Phillips, Christopher H. Herbst, Yah Zolia

Publikováno v: Health Labor Market Analyses in Low-and Middle-Income Countries: An Evidence-Based Approach

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fc64e10c5c0436907365b3590b8a68a0
https://doi.org/10.1596/978-1-4648-0931-6_ch10

Reducing under-reporting of stigmatized health events using the List Experiment: results from a randomized, population-based study of abortion in Liberia

Autor: Eric Vittinghoff, Caitlin Gerdts, Bernice Dahn, Christine Dehlendorf, Robert A. Hiatt, Heidi Moseson, Luke Bawo, Moses Massaquoi, Yah Zolia

Publikováno v: International journal of epidemiology, vol 44, iss 6
Moseson, H; Massaquoi, M; Dehlendorf, C; Bawo, L; Dahn, B; Zolia, Y; et al.(2015). Reducing under-reporting of stigmatized health events using the List Experiment: results from a randomized, population-based study of abortion in Liberia. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 44(6), 1951-1958. doi: 10.1093/ije/dyv174. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/1749q01m

BackgroundDirect measurement of sensitive health events is often limited by high levels of under-reporting due to stigma and concerns about privacy. Abortion in particular is notoriously difficult to measure. This study implements a novel method to e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af547b9c9463f0b2781a6b9eeec0014
https://europepmc.org/articles/PMC5156336/

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial

Autor: Pascal Houzé, Parastou Valeh, Philippe J Guerin, Timothy Sundaygar, Jean-René Kiechel, Gwenaelle Carn, Eric Comte, Richard G. Smith, Elizabeth A. Ashley, Yah Zolia, Loretxu Pinoges, Joel J. Jones, Elisabeth Baudin, Birgit Schramm, Charles S Mazinda, Mehul Dhorda, Vincent Jullien, Yap Boum

Publikováno v: Malaria Journal
Malaria Journal, 2013, 12 (1), pp.251. ⟨10.1186/1475-2875-12-251⟩
Malaria Journal, BioMed Central, 2013, 12 (1), pp.251. ⟨10.1186/1475-2875-12-251⟩
Malaria Journal, BioMed Central, 2013, 12 (1), pp.251. 〈10.1186/1475-2875-12-251〉

Prospective efficacy monitoring of anti-malarial treatments is imperative for timely detection of resistance development. The in vivo efficacy of artesunate-amodiaquine (ASAQ) fixed-dose combination (FDC) was compared to that of artemether-lumefantri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8ecb1b6e7ca9b50c26217d55caad0e
https://www.hal.inserm.fr/inserm-00903747/document

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia

Autor: Gwenaelle Carn, Eric Comte, Elizabeth A. Ashley, Elisabeth Baudin, Richard G. Smith, Loretxu Pinoges, Yah Zolia, Vincent Jullien, Michel Branger, Joel J. Jones, Birgit Schramm, Jean-René Kiechel, Charles S Mazinda, Arnaud Bruneel, Philippe J Guerin, Parastou Valeh, Timothy Sundaygar

Publikováno v: Malaria Journal
Malaria Journal, BioMed Central, 2013, 12 (1), pp.250. ⟨10.1186/1475-2875-12-250⟩
Malaria Journal, 2013, 12 (1), pp.250. ⟨10.1186/1475-2875-12-250⟩
Malaria Journal, BioMed Central, 2013, 12 (1), pp.250. 〈10.1186/1475-2875-12-250〉

Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal. Two open-label, randomized trials were conducted in Nimba County, Liberia: i) t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24eb265ab015fe676b37005a9b6d4b4b